The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol

BACKGROUND: Percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) has been performed for the improvement of symptoms and quality of life in patients with stable angina. The ORBITA study demonstrated the role of the placebo effect in contemporary PCI in non-CTO chronic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sarosh, Fawaz, Samer, Simpson, Rupert, Robertson, Craig, Kelly, Paul, Mohdnazri, Shah, Tang, Kare, Cook, Christopher M., Gallagher, Sean, O’Kane, Peter, Spratt, James, Brilakis, Emmanouil S., Karamasis, Grigoris V., Al-Lamee, Rasha, Keeble, Thomas R., Davies, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188975/
https://www.ncbi.nlm.nih.gov/pubmed/37206100
http://dx.doi.org/10.3389/fcvm.2023.1172763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188975/
https://www.ncbi.nlm.nih.gov/pubmed/37206100
http://dx.doi.org/10.3389/fcvm.2023.1172763

Ejemplares similares